

Cover Story
FreeHealth Equity
By Matthew Bin Han Ong
A recent analysis of the National Cancer Institute’s workforce and grant recipients shows that Black and Hispanic scientists are dramatically underrepresented across key metrics, both intramural and extramural.
In Brief
Clinical Roundup
Drugs & Targets


NCI Trials


NCI Trials for July 2021
The National Cancer Institute approved the following clinical research studies last month. For further information, contact the principal investigator listed.
Trending Stories
- With five-year cancer survival at an all-time high, does this mean people are living longer?
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - House passes three-year extension of ACA subsidies with bipartisan support
- When “safe and effective” is not “reasonable and necessary”
We can curb excessive drug dosing and improve the quality of cancer care















